| Cover | Aug. 13, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Document Period End Date | Aug. 13, 2024 |
| Entity Registrant Name | Acumen Pharmaceuticals, Inc. |
| Entity Incorporation, State or Country Code | DE |
| Entity File Number | 001-40551 |
| Entity Tax Identification Number | 36-4108129 |
| Entity Address, Address Line One | 1210-1220 Washington Street |
| Entity Address, Address Line Two | Suite 210 |
| Entity Address, City or Town | Newton |
| Entity Address, State or Province | MA |
| Entity Address, Postal Zip Code | 22902 |
| City Area Code | 434 |
| Local Phone Number | 297-1000 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $0.0001 par value |
| Trading Symbol | ABOS |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Entity Ex Transition Period | false |
| Entity Central Index Key | 0001576885 |
| Amendment Flag | false |
